| Overall (N=37) |
|
|---|---|
Data are presented as incidence (frequency) or mean (standard deviation) | |
| Age at implantation (years) | |
| Mean (SD) | 67 (13) |
| Gender | |
| Male | 17 (46 %) |
| Female | 20 (54 %) |
| Preimplant Low-Frequency PTA (dB HL) | |
| Mean (SD) | 47 (13) |
| Postimplant Low-Frequency PTA (dB HL) | |
| Mean (SD) | 85 (20) |
| Electrode | |
| HiRes Ultra 3D | 7 (19 %) |
| Neuro Zti | 7 (19 %) |
| Nucleus® CI522 | 1 (3 %) |
| Nucleus® CI622 | 21 (57 %) |
| Nucleus® CI632 | 1 (3 %) |
| Intravenous dexamethasone | |
| No | 11 (30 %) |
| Yes | 26 (70 %) |
| Round window dexamethasone | |
| No | 19 (51 %) |
| Yes | 18 (49 %) |